Literature DB >> 32597833

A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.

Lakshya Bajaj1,2, Jaiprakash Sharma1,2, Alberto di Ronza1,2, Pengcheng Zhang3, Aiden Eblimit1, Rituraj Pal1,2, Dany Roman4, John R Collette4, Clarissa Booth5,6, Kevin T Chang1,2, Richard N Sifers4, Sung Y Jung7, Jill M Weimer5,6, Rui Chen1,8,9, Randy W Schekman3,10, Marco Sardiello1,2.   

Abstract

Lysosomal enzymes are synthesized in the endoplasmic reticulum (ER) and transferred to the Golgi complex by interaction with the Batten disease protein CLN8 (ceroid lipofuscinosis, neuronal, 8). Here we investigated the relationship of this pathway with CLN6, an ER-associated protein of unknown function that is defective in a different Batten disease subtype. Experiments focused on protein interaction and trafficking identified CLN6 as an obligate component of a CLN6-CLN8 complex (herein referred to as EGRESS: ER-to-Golgi relaying of enzymes of the lysosomal system), which recruits lysosomal enzymes at the ER to promote their Golgi transfer. Mutagenesis experiments showed that the second luminal loop of CLN6 is required for the interaction of CLN6 with the enzymes but dispensable for interaction with CLN8. In vitro and in vivo studies showed that CLN6 deficiency results in inefficient ER export of lysosomal enzymes and diminished levels of the enzymes at the lysosome. Mice lacking both CLN6 and CLN8 did not display aggravated pathology compared with the single deficiencies, indicating that the EGRESS complex works as a functional unit. These results identify CLN6 and the EGRESS complex as key players in lysosome biogenesis and shed light on the molecular etiology of Batten disease caused by defects in CLN6.

Entities:  

Keywords:  Cell Biology; Genetic diseases; Lysosomes; Molecular pathology

Mesh:

Substances:

Year:  2020        PMID: 32597833      PMCID: PMC7410054          DOI: 10.1172/JCI130955

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  81 in total

1.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways.

Authors:  Michela Palmieri; Soren Impey; Hyojin Kang; Alberto di Ronza; Carl Pelz; Marco Sardiello; Andrea Ballabio
Journal:  Hum Mol Genet       Date:  2011-07-13       Impact factor: 6.150

3.  Inhibition of secretion by 1,3-Cyclohexanebis(methylamine), a dibasic compound that interferes with coatomer function.

Authors:  T Hu; C Y Kao; R T Hudson; A Chen; R K Draper
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

4.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

Review 5.  Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases.

Authors:  Marco Sardiello
Journal:  Ann N Y Acad Sci       Date:  2016-05       Impact factor: 5.691

6.  ERp44 and ERGIC-53 synergize in coupling efficiency and fidelity of IgM polymerization and secretion.

Authors:  Margherita Cortini; Roberto Sitia
Journal:  Traffic       Date:  2010-05       Impact factor: 6.215

7.  Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease.

Authors:  Sophia-Martha Kleine Holthaus; Saul Herranz-Martin; Giulia Massaro; Mikel Aristorena; Justin Hoke; Michael P Hughes; Ryea Maswood; Olha Semenyuk; Mark Basche; Amna Z Shah; Izabela P Klaska; Alexander J Smith; Sara E Mole; Ahad A Rahim; Robin R Ali
Journal:  Hum Mol Genet       Date:  2019-12-01       Impact factor: 6.150

8.  ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes.

Authors:  Kazuto Yoshimi; Yayoi Kunihiro; Takehito Kaneko; Hitoshi Nagahora; Birger Voigt; Tomoji Mashimo
Journal:  Nat Commun       Date:  2016-01-20       Impact factor: 14.919

Review 9.  Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses.

Authors:  Alfried Kohlschütter; Angela Schulz; Udo Bartsch; Stephan Storch
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

10.  Enrichment and analysis of secretory lysosomes from lymphocyte populations.

Authors:  Hendrik Schmidt; Christoph Gelhaus; Ralph Lucius; Melanie Nebendahl; Matthias Leippe; Ottmar Janssen
Journal:  BMC Immunol       Date:  2009-07-29       Impact factor: 3.615

View more
  16 in total

Review 1.  Built to last: lysosome remodeling and repair in health and disease.

Authors:  Roberto Zoncu; Rushika M Perera
Journal:  Trends Cell Biol       Date:  2022-02-02       Impact factor: 21.167

Review 2.  Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses.

Authors:  Keigo Takahashi; Hemanth R Nelvagal; Jenny Lange; Jonathan D Cooper
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

3.  Quantitative glycoproteomics reveals cellular substrate selectivity of the ER protein quality control sensors UGGT1 and UGGT2.

Authors:  Benjamin M Adams; Nathan P Canniff; Kevin P Guay; Ida Signe Bohse Larsen; Daniel N Hebert
Journal:  Elife       Date:  2020-12-15       Impact factor: 8.140

4.  Neuronal Ceroid Lipofuscinosis Type 6 (CLN6) clinical findings and molecular diagnosis: Costa Rica's experience.

Authors:  R Badilla-Porras; A Echeverri-McCandless; J M Weimer; A Ulate-Campos; A Soto-Rodríguez; A Gutiérrez-Mata; L Hernández-Con; S Bogantes-Ledezma; A Balmaceda-Meza; J Brudvig; A Sanabria-Castro
Journal:  Orphanet J Rare Dis       Date:  2022-01-10       Impact factor: 4.123

5.  Efficient progranulin exit from the ER requires its interaction with prosaposin, a Surf4 cargo.

Authors:  Swathi Devireddy; Shawn M Ferguson
Journal:  J Cell Biol       Date:  2021-12-17       Impact factor: 8.077

Review 6.  Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).

Authors:  William D Kim; Morgan L D M Wilson-Smillie; Aruban Thanabalasingam; Stephane Lefrancois; Susan L Cotman; Robert J Huber
Journal:  Front Cell Dev Biol       Date:  2022-02-16

Review 7.  Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview.

Authors:  Alessandro Simonati; Ruth E Williams
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

Review 8.  Mechanisms regulating the sorting of soluble lysosomal proteins.

Authors:  İçten Meraş; Juliette Maes; Stephane Lefrancois
Journal:  Biosci Rep       Date:  2022-05-27       Impact factor: 3.976

Review 9.  Altered protein secretion in Batten disease.

Authors:  Robert J Huber
Journal:  Dis Model Mech       Date:  2021-12-06       Impact factor: 5.758

10.  CLN3, at the crossroads of endocytic trafficking.

Authors:  Susan L Cotman; Stéphane Lefrancois
Journal:  Neurosci Lett       Date:  2021-07-16       Impact factor: 3.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.